1. MitoKATP regulating HIF/miR210/ISCU signaling axis and formation of a positive feedback loop in chronic hypoxia-induced PAH rat model
   Yang Lu et al, 2017, Experimental and Therapeutic Medicine CrossRef
2. Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease
   Virginia Albiñana et al, 2017, Orphanet Journal of Rare Diseases CrossRef
3. Circulating miR-210 as a diagnostic and prognostic biomarker for colorectal cancer
   W. Wang et al, 2017, European Journal of Cancer Care CrossRef
4. The Regulatory Roles of MicroRNAs in Bone Remodeling and Perspectives as Biomarkers in Osteoporosis
   Mengge Sun et al, 2016, BioMed Research International CrossRef
5. Introducing, OncoTarget
   Mikhail Blagosklonny et al, 2010, Oncotarget CrossRef
6. miR-210 and GPD1L regulate EDN2 in primary and immortalized human granulosa-lutein cells
   Ketan Shrestha et al, 2018, Reproduction CrossRef
7. The dual role of MiR-210 in the aetiology of cancer: A focus on hypoxia-inducible factor signalling
   S. Afsar et al, 2024, Pathology - Research and Practice CrossRef
8. Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer
   Peng-Ju Gong et al, 2020, Frontiers in Oncology CrossRef
9. Identification and functional characterization of circRNA-0008717 as an oncogene in osteosarcoma through sponging miR-203
   Xiang Zhou et al, 2018, Oncotarget CrossRef
10. Small non-coding RNAs-based bone regulation and targeting therapeutic strategies
    Ying Yang et al, 2017, Molecular and Cellular Endocrinology CrossRef
11. Downregulation of RGMA by HIF-1A/miR-210-3p axis promotes cell proliferation in oral squamous cell carcinoma
    Yingjuan Lu et al, 2019, Biomedicine & Pharmacotherapy CrossRef
12. Effects of hypoxic‑ischemic pre‑treatment on microvesicles derived from endothelial progenitor cells
    Wen Zeng et al, 2020, Experimental and Therapeutic Medicine CrossRef